Acadia Pharmaceuticals | ACAD - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
ALKERMES USD 7.93B 806M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cara Therapeutics USD 110M 80M 2026-08
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Cytokinetics USD 9.6B 1.95B 2026-08
Eisai JPY 1.2T 219.32B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Incyte USD 26.84B 4.19B 2026-08
J&J USD 611.36B 32.21B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Prothena USD 516M 2M 2026-03
Sarepta Therapeutics USD 1.5B 402M 2026-08
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08